SCHEMBL6072891

SCHEMBL6072891

[CH2]CC[N+]1(C)CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
BBOX1 O75936 2/20 0.41
TP53 P04637 1/20 0.38
LMNA P02545 4/20 0.37
KMT2A Q03164 2/20 0.37
APOBEC3A P31941 2/20 0.37
APOBEC3G Q9HC16 2/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
CHRNA7 P36544 3/20 0.33
CDC25A P30304 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2401295 0.97
SCHEMBL6767920 0.82 KDM4E (0.59) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL9936384 0.78 KDM4E (0.55) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL2400137 0.77 LMNA (0.50) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL7166850 0.77 BBOX1 (0.56) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL384883 0.77 BBOX1 (0.56) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL4588375 0.77
SCHEMBL222638 0.74 KDM4E (0.52) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL3043744 0.74 LMNA (0.57) KDM4EBBOX1TP53LMNAKMT2A
SCHEMBL3037609 0.74 LMNA (0.57) KDM4EBBOX1TP53LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241149-A1 Chemical compounds ADAMS JERRY L 2006-10-26 US disclosed
EP-0106284-B1 3-ARYL-7-CHLORO-3,4-DIHYDRO-ACRIDINE-1,9-(2H,10H)-DIONE-1-OXIMES AND 1-HYDRAZONES, THEIR SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THEIR APPLICATION HOECHST AKTIENGESELLSCHAFT (DE) 1987-06-16 EP disclosed
EP-0106284-A1 3-Aryl-7-chloro-3,4-dihydro-acridine-1,9-(2H,10H)-dione-1-oximes and 1-hydrazones, their salts, process for their preparation and pharmaceutical preparations containing them, and their application HOECHST AKTIENGESELLSCHAFT (DE) 1984-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241149-A1 Chemical compounds CHKB, MAP3K20, MAP3K6 KDM4E 2777/4885BBOX1 558/4885TP53 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.